Ann Vasc Dis Vol. 6, No. 3; 2013; pp Online August 12, Annals of Vascular Diseases doi: /avd.oa Original Article

Similar documents
Selection criteria for PEA (UCSD)

Pulmonary Endarterectomy: Assessment of Operability, Surgical Description, and Post-op Care

DISTAL PULMONARY THROMBOENDARTERECTOMY: IS IT WORTH IT?

Pulmonary thromboendarterectomy (PTE) is indicated for

ORIGINAL ARTICLE. Editorial p 320. Methods. Pulmonary Circulation. 476 YAMAKI S et al.

The efficacy of pulmonary thromboendarterectomy on long-term gas exchange

CTEPH. surgical treatment. Ph. Dartevelle, E. Fadel, S. Mussot, D. Fabre, O. Mercier and G. Simonneau PARIS-SUD UNIVERSITY

Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension

The Pursuit of Minimally Invasive Pulmonary Thromboendarterectomy

The management of chronic thromboembolic pulmonary

Pulmonary Hypertension Surgical Options. Primary pulmonary hypertension. Transplantation. Thromboembolic disease Endarterectomy

Plasma Brain Natriuretic Peptide as a Noninvasive Marker for Efficacy of Pulmonary Thromboendarterectomy

Index. Note: Page numbers of article titles are in boldface type

Pulmonary Endarterectomy Improves Dyspnea by the Relief of Dead Space Ventilation

Case Report High-Flow Nasal Cannula Therapy in a Patient with Reperfusion Pulmonary Edema following Percutaneous Transluminal Pulmonary Angioplasty

Surgical Management in Chronic Thromboembolic Pulmonary Hypertension. Michael Bates, MD, FACS Ochsner Health System, New Orleans, LA

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland

PREOPERATIVE CARDIOPULMONARY ASSESSMENT FOR LIVER TRANSPLANTATION James Y. Findlay Mayo Clinic College of Medicine, Rochester, MN, USA.

Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations. Eric M. Graham, MD

Quantifying the learning curve for pulmonary thromboendarterectomy

CHAPTER X - SECONDARY PULMONARY HYPERTENSION CHRONIC PULMONARY THROMBOEMBOLISM (HTP). PULMONARY THROMBENDARTERECTOMY

Pulmonary Thromboembolectomy in Congenital Antithrombin III Deficiency Associated with Acute Pulmonary Embolism Report of a Case

The radial procedure was developed as an outgrowth

Chronic Thromboembolic Pulmonary Hypertension Lara M. Wittine, MD William R. Auger, MD *

Chronic Thromboembolic Pulmonary Hypertension Complicated by a Cavitating Lung Infection Caused by Mycobacterium intracellulare

Central extracorporeal membrane oxygenation for treatment of reperfusion oedema following pulmonary thromboendarterectomy: a case report

Real life management of CTEPH: patient case

Chronic Thromboembolic Pulmonary Hypertention CTEPH

Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension

Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension

Innovative ECMO Configurations in Adults

Pulmonary Artery Diameter Predicts Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension

Επεμβατικές στρατηγικές στην πνευμονική υπέρταση

Surgical Thrombectomy for PE: Is it Making a Comeback

Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia

Pulmonary Vasodilator Treatments in the ICU Setting

Complications of Acute Myocardial Infarction

WHY ADMINISTER CARDIOTONIC AGENTS?

Vascular Medicine. Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary Thromboendarterectomy

Patricia A. Thistlethwaite, MD, PhD, Aaron Kemp, BA, Lingling Du, MD, Michael M. Madani, MD, and Stuart W. Jamieson, MB, FRCS

Heart-lung transplantation: adult indications and outcomes

WHAT IS. Helping your patients understand their type of PH. Educational program by. Material endorsed by

Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, and Pulmonary Thromboendarterectomy Program

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community

Utility of Exercise-Induced Zero TBI Sign in Patients on Maintenance Hemodialysis

Nothing to Disclose. Severe Pulmonary Hypertension

WHAT IS CTEPH. Helping you understand your type of PH. Provided by Bayer to help education of the PH community

AllinaHealthSystem 1

SdO 2. p Hypothermic circulatory arrest: HCA n = 6 Continuous retrograde cerebral perfusion: retrograde cerebral perfusion: IRCP

Real-world experience with riociguat in CTEPH

Saphenous Vein Autograft Replacement

Combination Therapy With Oral Sildenafil and Beraprost for Pulmonary Arterial Hypertension Associated With CREST Syndrome

Chronic thromboembolic pulmonary hypertension in pediatric patients

Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

ΔΙΑΓΝΩΣΗ ΚΑΙ ΘΕΡΑΠΕΙΑ ΤΗΣ ΧΡΟΝΙΑΣ ΘΡΟΜΒΟΕΜΒΟΛΙΚΗΣ ΥΠΕΡΤΑΣΗΣ (CTEPH)

In 1980, Bex and associates 1 first introduced the initial

The Case of Lucia Nazzareno Galiè, M.D.

Thrombophilia and Pulmonary Endarterectomy

Airway Management in a Patient with Klippel-Feil Syndrome Using Extracorporeal Membrane Oxygenator

CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

debris + 3 debris debris debris Tel: ,3

Index. Note: Page numbers of article titles are in boldface type.

ACTIVITY DESCRIPTION Target Audience Learning Objectives

Extra Corporeal Life Support for Acute Heart failure

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension

From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension

Disease of the aortic valve is frequently associated with

Αγγειοπλαστική των πνευμονικών αρτηριών στην χρόνια θρομβοεμβολική πνευμονική υπέρταση. Παρόν και μέλλον

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

DECLARATION OF CONFLICT OF INTEREST

Comparative Study of Cerebral Protection during Surgery of Thoracic Aortic Aneurysm

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Surgical treatment of chronic thromboembolic pulmonary hypertension

Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery

An anterior aortoventriculoplasty, known as the Konno-

Chronic post-embolic pulmonary hypertension: a new target for medical therapies?

Repair or Replacement

Open fenestration for complicated acute aortic B dissection

Introduction. Shinichiro Abe 1 Keiichi Ishida. Hiroki Kohno 1 Kaoru Matsuura. Goro Matsumiya 1

Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy

Atrial fibrillation (AF) is associated with increased morbidity

Citation Acta medica Nagasakiensia. 1994, 39

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

Definition: HPS is a disease process with a triad of: 1- Liver disease. 2- Widespread intrapulmonary vasodilatation. 3- Gas exchange abnormality prese

Disclosure Information : No conflict of interest

Chronic thromboembolic pulmonary hypertension (CTEPH) and the essential role of imaging specialists PP-ADE-ALL

What is. InSpectra StO 2?

Persistent Dyspnea After Pulmonary Embolism

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

Dr. Md. Rajibul Alam Prof. of Medicine Dinajpur Medical college

ECLS as Bridge to Transplant

Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques

Chapter 8. F.A. Klok, K.W. van Kralingen, A.P.J. van Dijk, F.H. Heyning, H.W. Vliegen and M.V. Huisman. Haematologica 2009; in press

Percutaneous Cardiopulmonary Support after Acute Myocardial Infarction at the Left Main Trunk

Management of a Patient after the Bidirectional Glenn

Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure

The evolution of the Fontan procedure for single ventricle

Transcription:

Ann Vasc Dis Vol. 6, No. 3; 2013; pp 578 582 Online August 12, 2013 2013 Annals of Vascular Diseases doi:10.3400/avd.oa.13-00056 Original Article Respiratory and Hemodynamic Changes in Patients with Chronic Thromboembolic Pulmonary Hypertension 1 Year after Pulmonary Endarterectomy Masato Sato, MD, PhD, Motomi Ando, MD, PhD, Kan Kaneko, MD, PhD, Yoshiro Higuchi, MD, PhD, Hiroshi Kondo, MD, PhD, Kiyotoshi Akita, MD, PhD, Michiko Ishida, MD, PhD, and Yasushi Takagi, MD, PhD We reviewed the results of thromboembolectomy, which was performed for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH), 1 year after the operation. We obtained hemodynamic and respiratory data of 60 patients from the 112 patients who were operated at our institute. The hemodynamic parameters such as mean pulmonary arterial pressure (PAP), pulmonary vascular resistance (PVR), and cardiac index (CI) were significantly improved after the operation, and this improvement of pulmonary hemodynamics persisted even a year after the operation. A significant improvement in gas exchange was observed immediately after the operation and a further elevation in the partial pressure of oxygen in arterial blood (PaO 2 ) was observed 1 year after the operation. (*English Translation of J Jpn Coll Angiol 2012; 52: 53-58) Keywords: chronic thromboembolic pulmonary hypertension, pulmonary endarterectomy, hemodynamic and respiratory outcome Introduction Department of Cardiovascular Surgery, Fujita Health University, Toyoake, Aichi, Japan Received: June 25, 2013; Accepted: July 2, 2013 Corresponding author: Masato Sato, MD, PhD. Otsuka Clinic, Minami- Otsuka Ace Building, 3-34-6-401, Minami-Otsuka, Toshima-ku, Tokyo 170-0005, Japan Tel: +81-3-3984-2246, Fax: +81-3-3984-8812 E-mail: buhichan520@yahoo.co.jp *This article is English Translation of J Jpn Coll Angiol 2012; 52: 53-58. Chronic thromboembolic pulmonary hypertension (CTEPH) resists medical treatments, and pulmonary endarterectomy is the only effective radical treatment presently available. 1 3) At our facility, this procedure has been performed preferentially in patients with CTEPH since 2001, with marked respiratory and hemodynamic improvements immediately after surgery in many patients. After discharge, the respiratory and hemodynamics have been carefully followed up by admitting the patients after 1, 3, and 5 years. In this study, we examined whether or not the satisfactory respiratory and hemodynamic conditions immediately after surgery were maintained after 1 year. Subjects and Methods Of the 112 patients with CTEPH who underwent pulmonary endarterectomy at our institute between August 2001 and September 2010, 60 who were successfully discharged were admitted to our institute for examination after about 1 year, and selected as the subjects. They consisted of 12 males and 48 females, with a mean age of 54.8 years. The data concerning the respiratory and hemodynamics obtained by right heart catheterization, echocardiography, pulmonary perfusion scintigraphy, and blood tests before, after (immediately before discharge), and 1 year after surgery were comparatively evaluated. Statistical analyses were performed by the t-test and c 2 -test at the p <0.05 level of significance. Surgical indications: Similarly to Jamieson, et al., surgery was indicated when: 1) The mean pulmonary artery pressure (PAP) was 30 mmhg and pulmonary vascular resistance (PVR) was 300 dyne sec cm 5, 2) the proximal 578 Annals of Vascular Diseases Vol. 6, No. 3 (2013)

Table 1 Peri-operative data (n = 60) Age (years) 54.8 ± 9.9 Gender (Male/Female) 12/48 IVC filter (n) 28 Thrombophilia (n) 3 (APS: 3) PCPS induction (n) 11 (Proximal type: 6, Distal type: 5) Distal type (n) 14 Operation time (min) 405 ± 68.7 Total circulatory arrest time (min) 56.9 ± 14.6 ICU stay (days) 12.1 ± 11.0 Tracheostomy (n) 2 IVC filter: inferior vena cava filter; PCPS: percutaneous cardiopulmonary support; ICU: intensive care unit; APS: anti-phospholipid antibody syndrome Resp. and Hemodynamics in CTEPH Patients 1 Year after PEA end of the thrombus was located at a surgically accessible site, and 3) there was no serious complication. 1) The morphology of pulmonary artery obstruction was examined by pulmonary arteriography, truncal computed tomography (CT), and pulmonary perfusion scintigraphy, and patients with obstruction only distal to the subsegmental arteries were excluded from surgical candidates. Surgery was indicated when the preoperative clinical condition was New York Heart Association (NYHA) III or above without shock, in principle. In patients who preoperatively showed exacerbation of respiratory and cardiovascular dynamics, surgery was performed after improving the condition by medical treatments, i.e., rest by hospitalization, oxygen administration, and drug therapy (epoprostenol drip infusion, oral administration of bosentan, sildenafil, etc.). Surgical procedure: Surgery was performed using the method established by the San Diego Group. 1,4) The approach was made by a median sternotomy, extracorporeal circulation was established with blood inflow through the ascending aorta and outflow through the superior and inferior vena cava, the and blood was cooled until the core body temperature was reduced to 18 C. Retractors were applied between the ascending aorta and superior vena cava, anterior aspect of the right main pulmonary artery was incised longitudinally, and the endarterectomy plane was identified. The ascending aorta was clamped, ante- and retrograde cardioplegic solutions were infused, and, when the core body temperature reached 18 C, endarterectomy was performed toward the segmental artery using special forceps. Circulatory arrest was maintained for 15 minutes at a time, and the periods of circulatory arrest were interposed by 10-minute systemic perfusion, during which the ante- and retrograde cardioplegic solutions were infused. After endarterectomy of the right pulmonary artery was completed by several circulatory arrests, the systemic circulation was resumed, and the incision was closed by suturing. Next, the heart was retracted to the right and inferiorly using a heart net, the left main pulmonary artery was incised, and endarterectomy was performed by intermittent circulatory arrests similarly to the right pulmonary artery. After the completion of endarterectomy, the systemic circulation was restored, and the incision was closed while normalizing the body temperature. After recovery of the normal body temperature, weaning from the cardiopulmonary bypass was attempted. In patients showing marked pulmonary hypertension persisting even with the use of catecholamines, vasodilators, etc., a pulmonary artery pressure nearly equal to the systemic blood pressure, preventing the maintenance of the hemodynamics, or severe airway bleeding, PCPS was applied before weaning from extracorporeal circulation and closing the sternal incision. Results Table 1 shows the perioperative data of the 60 patients. There were 14 patients with distal-type CTEPH with lesions located primarily distal to the segmental arteries. Postoperative PCPS was applied to 11, of whom 6 had proximal-type CTEPH. The mean operation time was 405 minutes, and the mean total cardiac arrest time was 56.9 minutes. The mean duration of intensive care unit (ICU) care was 12.1 days, and tracheotomy was performed in 2 patients who required long-term respiratory management. Changes in the mean PAP (Fig. 1), PVR (Fig. 2), cardiac index (CI) (Fig. 3), partial pressure of oxygen under room air (Fig. 4), brain natriuretic peptide (BNP) (Fig. 5), and NYHA grade (Fig. 6) before, after (before discharge), and 1 year after surgery are presented. The mean pulmonary artery pressure was 49.1 ± 11.8 mmhg before surgery, Annals of Vascular Diseases Vol. 6, No. 3 (2013) 579

Sato M, et al. Fig. 1 Changes in pulmonary arterial pressure (PAP) (mean). Fig. 3 Changes in cardiac index (CI). Fig. 2 Changes in pulmonary vascular resistance (PVR). Fig. 4 Changes in PaO 2 under room air. Fig. 5 Changes in brain natriuretic peptide (BNP). Fig. 6 Changes in New York Heart Association (NYHA) Class. 580 Annals of Vascular Diseases Vol. 6, No. 3 (2013)

Resp. and Hemodynamics in CTEPH Patients 1 Year after PEA significantly decreased after surgery to 21.6 ± 9.7 mmhg (p <0.001), and was 23.1 ± 10.7 mmhg after 1 year, showing no significant change. The pulmonary vascular resistance was 997.5 ± 340.0 dyne sec cm 5 before surgery, decreased significantly after surgery to 268.8 ± 176.2 dyne sec cm 5 (p <0.001), and was 278.3 ± 231.8 dyne sec cm 5 1 year after surgery, showing no significant change. The CI was 2.30 ± 0.65 l/min/m 2 before surgery, significantly increased to 3.00 ± 0.73 l/min/m 2 after surgery (p <0.001), and was 3.02 ± 0.95 l/min/m 2 1 year after surgery, showing no significant change. The partial pressure of oxygen in room air was 58.8 ± 8.8 mmhg before surgery, significantly increased to 70.0 ± 16.0 mmhg after surgery (p <0.001), and increased further to 79.3 ± 13.8 mmhg 1 year after surgery (p <0.001). The blood BNP level was 371.5 ± 382.2 pg/ml before surgery, significantly decreased after surgery to 91.6 ± 74.0 pg/ml (p <0.01), and significantly decreased again 1 year after surgery to 51.2 ± 44.0 pg/ml (p <0.01). The number of patients classified as NYHA III or higher was 48 before surgery but significantly decreased to 1 after surgery, and the percentage of patients classified as NYHA I increased further after 1 year. Discussion The values of hemodynamic parameters such as the mean pulmonary artery pressure, pulmonary vascular resistance, and CI improved markedly after (before discharge) compared with before surgery. No further improvement was observed after 1 year, but a satisfactory state was maintained. However, the partial pressure of oxygen improved significantly after surgery and improved further after 1 year. While more than half of the patients required home oxygen therapy at discharge, those requiring the therapy decreased after 1 year. It has been reported that improvements in hemodynamics are observed from shortly after pulmonary endarterectomy, but that there is a time lag before improvements in the partial pressure of oxygen, and Tanabe et al. 5) reported that improvements in the gas exchange capacity required 6 24 months after surgery. There have been the following reports concerning the reason for this delay: 1) Direct effects of surgery: Hypoxemia is caused early after surgery by impaired diffusion due to ventilation-perfusion imbalance and pulmonary edema as a result of a reduced respiratory function due to sternotomy, postoperative atelectasis, and pleural adhesion. 2) Vascular steal phenomenon: On pulmonary perfusion scintigraphy early after surgery, the areas in which the blood flow has been restored by endarterectomy are delineated as hyperperfused areas, but non-endarterectomized areas appear as new hypoperfused areas (vascular steal phenomenon), but this phenomenon gradually disappears on long-term postoperative follow-up with resolution of hypoxia. 3) Intrapulmonary shunts are increased. However, there has also been a report that dyspnea was resolved with a decrease in dead space ventilation after endarterectomy, but that the decrease in dead space ventilation was not directly correlated with changes in the hemodynamics. 6) Of the subjects in this study, 8 patients showed persisted pulmonary hypertension: the mean pulmonary artery pressure before discharge was 30 mmhg. Distal type was 3, and PCPS was used in 2 with distal-type and 1 with proximal-type CTEPH. While all patients were alive 1 year after surgery, pulmonary hypertension was exacerbated compared with the preoperative state in 2. The surgical indications of distal-type CTEPH must be carefully evaluated, 7) but surgery is not very effective, and pulmonary hypertension persists in some patients with proximal-type CTEPH, making treatment of this disease difficult. The 60 subjects of this study were all discharged alive, but surgery-related deaths were observed in 12 (9.8%) of the 112 patients who underwent surgery during this period. This number includes those treated shortly after the initiation of this procedure at our institute, and surgery-related deaths decreased to 2 out of the 74 patients treated after 2006, when the modifications of the perioperative management and surgical procedure were introduced. These outcomes are almost same as those reported by the San Diego Group (<4% in the recent 200 cases) 3) or other facilities (6.9% 24%). 8 11) Conclusion The respiratory and hemodynamic conditions of CTEPH patients improved by pulmonary endarterectomy were maintained, and the partial pressure of oxygen was further improved after 1 year. Disclosure Statement None of the authors has any conflicts of interest to disclose. Annals of Vascular Diseases Vol. 6, No. 3 (2013) 581

Sato M, et al. References 1) Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106: 116-26; discussion 126-7. 2) Ando M, Yamashita M, Sato M, et al. Surgical treatment for chronic pulmonary thromboembolism. J Jpn Surg Soc 2005; 106: 252-7. (in Japanese) 3) Thistlethwaite PA, Kaneko K, Madani MM, et al. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 2008; 14: 274-82. 4) Daily PO, Dembitsky WP, Iversen S. Technique of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Card Surg 1989; 4: 10-24. 5) Tanabe N, Okada O, Nakagawa Y, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066-72. 6) van der Plas MN, Reesink HJ, Roos CM, et al. Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation. Ann Thorac Surg 2010; 89: 347-52. 7) Sato M, Ando M, Yamashita M, et al. Postoperative use of a percutaneous cardiopulmonary support device after pulmonary thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension. Jpn J Phlebol 2009; 20: 37-42. 8) Mellemkjaer S, Ilkjaer LB, Klaaborg KE, et al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark. Scand Cardiovasc J 2006; 40: 49-53. 9) Corsico AG, D Armini AM, Cerveri I, et al. Longterm outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008; 178: 419-24. 10) Saouti N, Morshuis WJ, Heijmen RH, et al. Longterm outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience. Eur J Cardiothorac Surg 2009; 35: 947-52; discussion 952. 11) Matsuda H, Ogino H, Minatoya K, et al. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006; 82: 1338-43; discussion 1343. 582 Annals of Vascular Diseases Vol. 6, No. 3 (2013)